SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis is seeing active community discussion following its recent NYSE debut and the emergence of institutional interest in the sector. Investors are weighing the impact of upcoming legislative hearings and company-specific leadership changes against long-term growth opportunities in the U.S. medical cannabis market.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as the community highlights its recent v4 launch and the implementation of a revenue-sharing model for node runners and stakers. Investors are focused on the project's significant supply scarcity, with a large majority of the float currently locked in long-term staking pools.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum is capturing market attention as investors identify it as a potentially pivotal pure-play software provider in the quantum computing ecosystem. The stock is seeing heightened volatility and interest driven by its ultra-low float and strategic partnerships with major hardware players, leading the community to actively debate its long-term valuation relative to peers.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is a central point of discussion as investors debate whether recent price weakness represents a healthy consolidation or a warning sign for the broader AI-driven bull market. Community sentiment is currently polarized between those viewing this as an opportunistic rotation into oversold mega-caps and others who fear that unsustainable capital expenditure and shifting macroeconomic conditions signal a looming peak for the group.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently attracting intense community debate as investors weigh the potential of its ITK inhibitor, soquelitinib, against significant downward price pressure and high short interest. While proponents highlight ongoing institutional accumulation and a long-term 'pipeline-in-a-product' narrative, bears are focused on the lack of immediate revenue, recurring dilution, and the high-risk nature of its early-stage clinical pipeline.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is generating significant community interest as investors weigh its strong fundamentals, operational efficiency, and potential acquisition activity against the broader volatility in global oil markets. Traders are actively discussing the company's prospects in light of Middle Eastern supply concerns, focusing on how its low break-even costs and potential for increased takeaway capacity could drive long-term value despite short-term fluctuations.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is currently sparking intense debate within the crypto community, with some investors dismissing the project as a scam while others remain optimistic, viewing recent price movements as a potential setup for a significant rally. Discussions are heavily focused on speculative 10x-to-50x growth targets, debates over potential ETF applications, and broader market sentiment regarding meme coins and upcoming crypto-friendly political developments.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending as investors aggressively position themselves ahead of upcoming quarterly earnings and the highly anticipated Cerebras Systems IPO, viewing the stock as a strategic proxy for AI compute demand. Community sentiment is driven by the companys recent infrastructure contracts and its role in the AI data center buildout, though discussions also reflect high volatility and skepticism regarding leadership and execution.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending as investors react to a wave of bullish analyst initiations that cite the company's wafer-scale chip technology as a strong challenger in the AI inference market. While some community members are optimistic about its potential to disrupt incumbents, others remain cautious, pointing to concerns over lock-up expirations, valuation multiples, and the competitive dominance of established GPU architectures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant)

Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) PR Newswire SOUTH SAN FRANCISCO, Calif., June 16, 2026 SOUTH SAN FRANCISCO, Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.(Nasdaq...

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel to Present at the Jefferies Global Healthcare Conference Rigel to Present at the Jefferies Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., May 27, 2026 SOUTH SAN FRANCISCO, Calif., May 27, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial...

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress PR Newswire SOUTH SAN FRANCISCO, Calif., May 21, 2026 Oral presentation at ASCO Annual Meeting to...

Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference

Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif...

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.read more...

RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside?

Equity

Rigel Pharmaceuticals signed a global licensing deal with Arvinas and Pfizer for an advanced breast cancer treatment.

Rigel Pharma Signs Licensing Agreement With Arvinas And Pfizer For Veppanu

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) on Tuesday said it has entered into a global license agreement with Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE) to develop, manufacture and commercialize beast cancer treatment Veppanu...

Rigel Enters Exclusive Global Licensing Agreement for VEPPANU (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer

Rigel Enters Exclusive Global Licensing Agreement for VEPPANU (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer Rigel Enters Exclusive...

Rigel Pharmaceuticals Q1 Earnings Call Highlights

Rigel Pharmaceuticals (NASDAQ:RIGL) reported first-quarter 2026 results that management said reflected continued year-over-year growth across its three-product portfolio, while reiterating full-year guidance and highlighting upcoming data milestones for its R289 program in lower-risk myelodysplastic...

Rigel Pharmaceuticals Inc. Profit Falls In Q1

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) announced earnings for first quarter that Dropped, from last year...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$32.91
Prev Close	$33.37
Open	$33.99
Dividend Yield	0.00%
50-Day Moving Average	$30.19
Beta	1.29
Avg. Volume	443,272.23
PE Ratio	1.76

52-Week High	$52.24
52-Week Low	$18.14
Market Capitalization	$608.9M
EPS (Annual)	$19.48
Price to Book	1.52
Revenue Per Employee	$1.69M

RIGLRigel Pharmaceuticals

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RIGL News